Interferon-γ elicits arteriosclerosis in the absence of leukocytes
Top Cited Papers
- 1 January 2000
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 403 (6766) , 207-211
- https://doi.org/10.1038/35003221
Abstract
Atherosclerosis and post-transplant graft arteriosclerosis are both characterized by expansion of the arterial intima as a result of the infiltration of mononuclear leukocytes, the proliferation of vascular smooth muscle cells (VSMCs) and the accumulation of extracellular matrix1,2,3. They are also associated with the presence of the immunomodulatory cytokine interferon-γ (IFN-γ)2,3. Moreover, in mouse models of atheroma formation or allogeneic transplantation, the serological neutralization4 or genetic absence5,6,7,8 of IFN-γ markedly reduces the extent of intimal expansion. However, other studies have found that exogenous IFN-γ inhibits cultured VSMC proliferation9,10,11,12,13,14 and matrix synthesis15, and reduces intimal expansion in response to mechanical injury16,17,18. This discrepancy is generally explained by the idea that IFN-γ either directly activates macrophages, or, by increasing antigen presentation, indirectly activates T cells within the lesions of atherosclerosis and graft arteriosclerosis. These activated leukocytes are thought to express the VSMC-activating cytokines1,2,3 and cell-surface molecules19 that cause the observed arteriosclerotic responses. Here we have inserted pig and human arteries into the aorta of immunodeficient mice, and we show that IFN-γ can induce arteriosclerotic changes in the absence of detectable immunocytes by acting on VSMCs to potentiate growth-factor-induced mitogenesis.Keywords
This publication has 26 references indexed in Scilit:
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts.Journal of Clinical Investigation, 1997
- IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.Journal of Clinical Investigation, 1997
- Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis.Journal of Clinical Investigation, 1996
- Mitogenic activity of interferon gamma on growth-arrested human vascular smooth muscle cells.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Interferon-γ inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generationBiochemical and Biophysical Research Communications, 1992
- Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Inhibition of Human Vascular Smooth Muscle Cell Proliferation by Interferon GammaAnnals of the New York Academy of Sciences, 1990
- Immune mechanisms in atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Lymphokine dependence of in vivo expression of MHC class II antigens by endotheliumNature, 1985